Videos

Aristides Maniatis, MD, FAAP explains how Sogroya reduces treatment burden and improves adherence for pediatric patients with growth disorders.

Pediatricians can use brief dietary screenings and policy advocacy to help families transition from ultra-processed foods toward minimally processed alternatives.

A study found that high consumption of ultra-processed foods in early childhood is associated with increased risks of anxiety, hyperactivity, and aggression.

Kara Margolis, MD, highlights how early life stress influences gastrointestinal health through the gut-brain axis.

A study found that prompt blood sugar control following a gestational diabetes diagnosis can reduce a child's risk of obesity.

Daniel Jaechul Ahn, MD, BS, explains how status exceptions are used to navigate the current 3-status system and why policy reform is necessary.

Researchers have found that reducing parental stress improves parenting behaviors and lowers obesity rates in children.

Children with Crohn disease had reduced microbial diversity and increased proinflammatory bacteria vs peers with disorders of brain-gut interaction.

Mariana Bueno, PhD, RN, discusses the physiological considerations, clinical barriers, and best practices for effectively using sucrose to mitigate procedural pain in infants.

A small dose of sucrose administered before painful hospital procedures is a simple and rapid method for reducing pain in newborns.

Clesrovimab has been shown to maintain RSV-protection in infants across 2 RSV seasons, while also having positive safety data.

Clinical trial data demonstrate that clesrovimab maintains a safety profile comparable to palivizumab while providing significant protection against RSV-related infections.

Brian Schroer, MD, highlights recent data exploring the origins of EoE inflammation and the efficacy and limitations of recent biologic treatments.

Carissa Baker-Smith, MD, MPH, outlines practical office-based interventions to help pediatricians effectively manage youth cardiovascular risk factors.

Carissa M. Baker-Smithm MD, MPH, outlines how pediatricians can mitigate long-term cardiovascular risk.

Hao Zhang, PhD, MPH, and Biaskha “Pia” Sen, PHD, discuss factors contributing to the rise in pediatric diabetes rates.

David Fleischer, MD, discusses how the VITESSE trial positions the VIASKIN peanut patch as a promising option for children with peanut allergy.

Druhan L. Howell, MD, discusses how new data on once-daily tapinarof show early, sustained improvements in itch and sleep outcomes.

A study found that cannabis use was associated with a doubled risk of psychotic and bipolar disorders.

Jolanta Bernatoniene, MD, PhD, discusses data showing oral berotralstat significantly reduces moderate and severe attacks in children with hereditary angioedema.

From 2010 to 2022, urban hospitals expanded access to advanced neonatal services while rural communities experienced a net loss.

Suicide rates and attempts among Black youth have surged over the past decade, highlighting critical risk factors and the need for proactive screening and community-based prevention strategies.

New research highlights the fluctuating course of pediatric ADHD and the continued role of stimulant medications as first-line therapy.

National survey data show a 35% increase in child mental health conditions since 2016, with one-fourth of households reporting unmet treatment needs.

Economic instability, food insecurity, discrimination, and low social support were associated with increased odds of pediatric long COVID.

New research shows widespread generative AI use among children and teens, prompting questions about potential impacts on social, mental, and sexual development.

Influenza antiviral treatment declined significantly among hospitalized children after COVID-19, highlighting gaps in guideline-recommended care.

Phase 2 data suggest FcRn blockade may reduce maternal IgG and placental antibody transfer in HDFN without excess infant infections.

Open-label data show sustained seizure reduction, stable safety, and improved quality of life in LGS treated with fenfluramine.

A new study finds high rates of neurodevelopmental diagnoses and service use among children undergoing heart surgery in infancy.